Use your antibodies-online credentials, if available.
Il n’y a pas de produits dans votre liste de comparaison.
Votre panier est vide.
Core binding factor (CBF) is a heterodimeric transcription factor that binds to the core element of many enhancers and promoters. De plus, nous expédions RUNX1 Kits (14) et RUNX1 Protéines (8) et beaucoup plus de produits pour cette protéine.
Showing 10 out of 279 products:
Human Polyclonal RUNX1 Primary Antibody pour WB - ABIN2668716
Zaidi, Dowdy, van Wijnen, Lian, Raza, Stein, Croce, Stein: Altered Runx1 subnuclear targeting enhances myeloid cell proliferation and blocks differentiation by activating a miR-24/MKP-7/MAPK network. dans Cancer research 2009
Show all 19 references for 2668716
Human Polyclonal RUNX1 Primary Antibody pour FACS, IF - ABIN650732
Moosavi, Sanchez, Adeyinka: Marker chromosomes are a significant mechanism of high-level RUNX1 gene amplification in hematologic malignancies. dans Cancer genetics and cytogenetics 2009
Show all 2 references for 650732
Human Polyclonal RUNX1 Primary Antibody pour ELISA, WB - ABIN1532121
Nucifora, Birn, Espinosa, Erickson, LeBeau, Roulston, McKeithan, Drabkin, Rowley: Involvement of the AML1 gene in the t(3,21) in therapy-related leukemia and in chronic myeloid leukemia in blast crisis. dans Blood 1993
Cow (Bovine) Polyclonal RUNX1 Primary Antibody pour WB - ABIN2792628
Takeshita, Ichikawa, Nitta, Goyama, Asai, Ogawa, Chiba, Kurokawa: AML1-Evi-1 specifically transforms hematopoietic stem cells through fusion of the entire Evi-1 sequence to AML1. dans Leukemia 2008
Cow (Bovine) Polyclonal RUNX1 Primary Antibody pour WB - ABIN2780380
Ghozi, Bernstein, Negreanu, Levanon, Groner: Expression of the human acute myeloid leukemia gene AML1 is regulated by two promoter regions. dans Proceedings of the National Academy of Sciences of the United States of America 1996
results demonstrate that RUNX1, when uncoupled from the requirement for cooperative ETS1 binding, is sufficient to drive long-range loop formation by the enhancer Ebeta, nucleosome clearance at its target promoters, and full transcriptional activation of the TCR beta recombination center
hemogenic competency in recently specified endothelial progenitors is restrained through the active silencing of Runx1 expression.
Leukaemogenesis by AML1-ETO (Montrer RUNX1T1 Anticorps) requires enhanced C/D box snoRNA/RNP (Montrer RNPC3 Anticorps) formation.
In this study, we found upregulation of several hemostasis-related genes, including the thrombin (Montrer F2 Anticorps)-activatable receptor PAR-1 (protease-activated receptor-1 (Montrer F2R Anticorps)), in Runx1/Cbfb (Montrer CBFB Anticorps)-deleted MLL (Montrer MLL Anticorps)-AF9 (Montrer MLLT3 Anticorps) cells. Similar to the effect of Runx1/Cbfb (Montrer CBFB Anticorps) deletion, PAR-1 (Montrer MARK2 Anticorps) overexpression induced CDKN1A/p21 (Montrer CDKN1A Anticorps) expression and attenuated proliferation in MLL (Montrer MLL Anticorps)-AF9 (Montrer MLLT3 Anticorps) cells
Immunohistochemical staining for RUNX1 showed reactivity in angiogenic tufts in the retina of mice with oxygen-induced retinopathy, suggesting that RUNX1 upregulation is a hallmark of aberrant retinal angiogenesis.
The Runx1-persistent group is involved in transmitting mechanical and thermal information, whereas the Runx1-transient group transmits pruriceptive information. Such hierarchical control mechanisms may provide a developmental solution for the formation of sensory circuits that transmit distinct modalities.
RUNX1 was expressed in both mesenchymal and epithelial compartments of the developing and postnatal lung. Increased respiratory distress, inflammation, and proinflammatory cytokines were observed in the Runx1-deleted mice after pulmonary LPS (Montrer TLR4 Anticorps) exposure. RUNX1 deletion was associated with the activation of NF-kappaB (Montrer NFKB1 Anticorps) in respiratory epithelial cells. RUNX1 was required for the suppression of NF-kappaB (Montrer NFKB1 Anticorps) signaling pathway.
both repressor and activator functions of Runx1 at multiple hematopoietic stages and lineages likely contribute to the tumor suppressor activity in MDS (Montrer MECOM Anticorps) and AML.
Knock-down of PLC-gamma-1 (Montrer PLCG1 Anticorps) induced foreign body giant cell formation.PLC-gamma-1-deficiency caused a decrease in RUNX1 and subsequent PU.1 upregulation while subsequent rescue of RUNX1 in sh-PLC-gamma-1 (Montrer PLCG1 Anticorps)-transfected cells strongly inhibited foreign body giant cell formation.
this study shows that distinct, asynchronous and stage-specific transcription factors (TCF-1 (Montrer HNF1A Anticorps), GATA-3 (Montrer GATA3 Anticorps) and Runx1) activate Bcl11b (Montrer BCL11B Anticorps) for T cell commitment
Our findings strengthen previous data concerning RUNX1 mutations in acute myeloid leukemia (Montrer BCL11A Anticorps) and support the notion that RUNX1 mutational status should be integrated into a diagnostic workup of acute myeloid leukemia (Montrer BCL11A Anticorps).
Heterozygous germ line mutations in the RUNX1 gene are responsible genetic events for FPD/AML.
Data suggest that RUNX1 pays dual roles in normal female sexual development/maturation and tumorigenesis in female-related cancers; "alterations" in RUNX1, either mutations in RUNX1 gene or variations in expression of RUNX1, appear to be associated with breast, ovarian, uterine, and cervical neoplasms. [REVIEW]
The E3 ubiquitin ligase (Montrer MUL1 Anticorps) STUB1 (Montrer STUB1 Anticorps) is a negative regulator of both RUNX1 and RUNX1-RUNX1T1 (Montrer RUNX1T1 Anticorps). Activation of STUB1 (Montrer STUB1 Anticorps) could be a promising therapeutic strategy for RUNX1-RUNX1T1 (Montrer RUNX1T1 Anticorps) leukemia.
The clinical significance of ETV6 (Montrer ETV6 Anticorps)-RUNX1.
Deliver the necessary promotional drive for the progression of ETV6 (Montrer ETV6 Anticorps)-RUNX1+ pre-leukaemic cells.
High RUNX1 expression is associated with pancreatic cancer.
these findings have identified a novel function for Runx1 in sustaining normal mammary epithelial morphology and preventing epithelial-mesenchymal transition
Our data suggest that runx1 and cbfb are required at 2 different steps during early hematopoietic stem cell development
We propose that cohesin and CTCF (Montrer CTCF Anticorps) have distinct functions in the regulation of runx1 during zebrafish embryogenesis.
Morpholino knockdown of Myef2 (Montrer MYEF2 Anticorps) or Runx1 in zebrafish results in reduced numbers of hematopoietic stem cells, suggesting that these two factors also interact in vivo to regulate hematopoiesis.
Runx1 is induced by high Pu.1 level and in turn transrepresses pu.1 expression, thus constituting a negative feedback loop that fashions a favorable Pu.1 level required for balanced fate commitment to neutrophils versus macrophages.
hematopoietic stem cell numbers depended on activity of the transcription factor Runx1, on blood flow, and on proper development of the dorsal aorta
in zebrafish adult HSCs can be formed without an intact runx1.
Zebrafish embryos lacking Rad21 (Montrer RAD21 Anticorps), or cohesin subunit Smc3 (Montrer SMC3 Anticorps), fail to express runx3 (Montrer RUNX3 Anticorps) and lose hematopoietic runx1 expression in early embryonic development.
Xaml1/Runx1 is required for the specification of Rohon-Beard sensory neurons in Xenopus.
ETV6-RUNX1 (TEL-AML1) fusion and hyperdiploidy (>50 chromosomes) are favorable genetic features in childhood acute lymphoblastic leukemia (ALL).
reveal a shift in Runx2 (Montrer RUNX2 Anticorps) function protein during vertebrate evolution towards its exclusive roles in cartilage hypertrophy and bone differentiation within the amniote lineage
Core binding factor (CBF) is a heterodimeric transcription factor that binds to the core element of many enhancers and promoters. The protein encoded by this gene represents the alpha subunit of CBF and is thought to be involved in the development of normal hematopoiesis. Chromosomal translocations involving this gene are well-documented and have been associated with several types of leukemia. Three transcript variants encoding different isoforms have been found for this gene.
runt-related transcription factor 1
, runt-related transcription factor 1 (acute myeloid leukemia 1; aml1 oncogene)
, runt-related transcription factor
, runt protein
, PEA2-alpha B
, PEBP2-alpha B
, SL3-3 enhancer factor 1 alpha B subunit
, SL3/AKV core-binding factor alpha B subunit
, acute myeloid leukemia 1 protein
, core binding factor alpha 2
, core-binding factor subunit alpha-2
, oncogene AML-1
, polyomavirus enhancer-binding protein 2 alpha B subunit
, runt domain, alpha subunit 2
, AML1-EVI-1 fusion protein
, core-binding factor, runt domain, alpha subunit 2
, runt-related transcription factor a
, Acute myeloid leukemia 1 protein
, Core-binding factor subunit alpha-2
, aml1 oncogene
, acute myeloid leukemia 1
, factor, runt domain, alpha subunit 2
, core-binding factor runt domain alpha subunit 2 (acute myeloid leukemia 1 oncogene)
, runt related transcription factor 1